J Korean Med Sci.  2016 Nov;31(Suppl 2):S168-S177. 10.3346/jkms.2016.31.S2.S168.

The Burden of Cancer in Korea during 2012: Findings from a Prevalence-Based Approach

• Gong YH
• Yoon SJ
• Jo MW
• Kim A
• Kim YA
• Yoon J
• Seo H
• Kim D

• KMID: 2360667
• DOI: http://doi.org/10.3346/jkms.2016.31.S2.S168

Abstract

Cancer causes a significant deterioration in health and premature death and is a national socioeconomic burden. This study aimed to measure the burden of cancer using the disability-adjusted life year (DALY) metric based on the newly adopted methodology from the Global Burden of Disease Study in 2010. This study was conducted based on data from the Korean National Cancer Registry. The DALYs were calculated using a prevalence-based method instead of the incidence-based method used by previous studies. The total burden of cancer in 2012 was 3,470.79 DALYs per 100,000 persons. Lung cancer was the most prevalent cancer burden, followed by liver, stomach, colorectal, and breast cancer. The DALYs for lung, liver, stomach, colon and rectum, and pancreatic cancer were high in men, whereas the DALYs for breast, lung, stomach, colorectal, and liver cancer were high in women. Health loss from leukemia and cancer of the brain and nervous system was prevalent for those younger than age 20; from stomach, breast, and liver for those aged 30-50; and from lung, colon and rectum, and pancreas for a large proportion of individuals over the age of 60. The most important differences were that the DALYs were calculated by prevalence and that other components of the DALYs were measured by a population-based perspective. Thus, prevalence-based DALYs could provide more suitable data for decision making in the healthcare field.

Keyword

Burden of Disease; Disability-Adjusted Life Years; Neoplasms; Prevalence; Korea

MeSH Terms

Brain Neoplasms
Breast
Breast Neoplasms
Colon
Decision Making
Delivery of Health Care
Female
Humans
Korea*
Leukemia
Liver
Liver Neoplasms
Lung
Lung Neoplasms
Male
Methods
Mortality, Premature
Nervous System
Pancreas
Pancreatic Neoplasms
Prevalence
Rectum
Stomach

Figure

• 

  Fig. 1 Disability-adjusted life years according to sex for each cancer type. The blue bars represent years of life lost; the red bars represent years lived with disability.

• 

  Fig. 2 Trends of disability-adjusted life years by age and sex. The blue lines represent male patients; the red lines represent female patients.

Reference

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136:E359–86.

2. National Cancer Center (KR). Annual Report of Cancer Statistics in Korea in 2012. Ilsan: National Cancer Center;2014.

3. Kim SG, Hahm MI, Choi KS, Seung NY, Shin HR, Park EC. The economic burden of cancer in Korea in 2002. Eur J Cancer Care (Engl). 2008; 17:136–144.

4. Kim J, Hahm MI, Park EC, Park JH, Park JH, Kim SE, Kim SG. Economic burden of cancer in South Korea for the year 2005. J Prev Med Public Health. 2009; 42:190–198.

5. Kim YA, Oh IH, Yoon SJ, Kim HJ, Seo HY, Kim EJ, Lee YH, Jung JH. The economic burden of breast cancer in Korea from 2007-2010. Cancer Res Treat. 2015; 47:583–590.

6. Murray CJ, Lopez AD. The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020 (Global Burden of disease and Injury Series Vol. 1). Cambridge, MA: Harvard University Press;1996.

7. Yoon SJ, Bae SC, Lee SI, Chang H, Jo HS, Sung JH, Park JH, Lee JY, Shin Y. Measuring the burden of disease in Korea. J Korean Med Sci. 2007; 22:518–523.

8. Oh IH, Yoon SJ, Kim EJ. The burden of disease in Korea. J Korean Med Assoc. 2011; 54:646–652.

9. Yoon SJ, Kim YI, Kim CY, Chang H. Measuring the burden of major cancers due to premature death in Korea. Korean J Prev Med. 2000; 33:231–238.

10. Park JH, Yoon SJ, Lee HY, Cho HS, Lee JY, Eun SJ, Park JH, Kim Y, Kim YI, Shin YS. Estimating the burden of psychiatric disorder in Korea. J Prev Med Public Health. 2006; 39:39–45.

11. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012; 380:2197–2223.

12. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012; 380:2163–2196.

13. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, et al. Supplementary Appendix to: Comprehensive Systematic Analysis of Global Epidemiology: Definitions, Methods, Simplification of DALYs, and Comparative Results from the Global Burden of Disease Study 2010. New York, NY. Lancet. 2012.

14. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, Shah R, Karyana M, Kosen S, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the global burden of disease study 2010. Lancet. 2012; 380:2129–2143.

15. Lee KS, Lee SI. A study on the reliability of in-hospital patient death information in health insurance claims: acute myocardial infarction and coronary artery bypass graft patients. Korean J Health Policy Adm. 2006; 16:37–51.

16. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012; 380:2063–2066.

17. Lee YR, Kim YA, Park SY, Oh CM, Kim YE, Oh IH. Application of a Modified Garbage Code Algorithm to Estimate Cause-Specific Mortality and Years of Life Lost in Korea. J Korean Med Sci. 2016; 31:Suppl 2. S121–S128.

18. Yoon SJ, Jo M, Park HS, Oh IH. A Study on Measuring and Forecasting the Burden of Disease in Korea. Seoul: Cardiovascular and Metabolic Diseases Etiology Research Center;2015.

19. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J. Cancer Incidence in Five Continents Vol. X. Lyon: International Agency for Research on Cancer;2014.

20. Lee BK. An analysis of ten year trends of cancer incidence and quality control of cancer registration data in Jeollabuk-do, Korea: 2001~2010. J Agric Med Community Health. 2014; 39:46–58.

21. Institute for Health Metrics and Evaluation (US). GBD compare [Internet]. accessed on 15 November 2015. Available at http://www.healthdata.org/data-visualization/gbd-compare.

22. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer “epidemic”--screening and overdiagnosis. N Engl J Med. 2014; 371:1765–1767.